Prognostic Biomarker Identification for Pancreatic Cancer by Analyzing Multiple mRNA Microarray and microRNA Expression Datasets
Possessing the five-year durability rate of nearly 5%, currently, the fourth leading cause for cancer-related deaths is pancreatic cancer. Previously, several works have resolved that early diagnosis performs a meaningful function in enhancing the durability rate and diverse online tools have been utilized to distinguish prognostic biomarker which is a lengthy process. We believe that the statistical feature selection method can produce a better and faster result here. To authenticate our statement, we picked three different mRNA microarray (GSE15471, GSE28735, and GSE16515) and a microRNA (GSE41372) dataset for identification of differentially expressed genes (DEGs) and differentially expressed microRNAs (DEMs). By adopting some feature selecting methods, 178 DEGs and 16 DEMs were elected. After identifying target genes of DEMs, we selected two DEGs (ECT2 and NRP2) which were also identified among DEMs target genes. Moreover, overall durability report established that ECT2 and NRP2 were associated with poor overall survival. Hence, we concluded that for pancreatic cancer, statistical feature selection approaches certainly perform better for biomarker identification than pre-defined online programs, and here, ECT2 and NRP2 can act as possible prognostic biomarkers. All the resources, programs and snippets of our literature can be discovered at https://github.com/Srizon143005/PancreaticCancerBiomarkers.
Code (1)
Tasks
feature selectionMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Optimizing Prognostic Biomarker Discovery in Pancreatic Cancer Through Hybrid Ensemble Feature Selection and Multi-Omics Data
Prediction of patient survival using high-dimensional multi-omics data requires systematic feature selection methods that ensure predictive performance, sparsity, and reliability for prognostic biomarker discovery. We de…
A Bioinformatics Study for Recognition of Hub Genes and Pathways in Pancreatic Ductal Adenocarcinoma
Background: The aim of this study is to use bioinformatics to discover the biomarkers associated with patients with Pancreatic Ductal Adenocarcinoma(PDAC). Material and Methods: GSE28735, GSE15471, and GSE62452 are gene …
DiagnosticRetrievalIdentification of Prognostic Biomarkers for Stage III Non-Small Cell Lung Carcinoma in Female Nonsmokers Using Machine Learning
Lung cancer remains a leading cause of cancer-related deaths globally, with non-small cell lung cancer (NSCLC) being the most common subtype. This study aimed to identify key biomarkers associated with stage III NSCLC in…
Radiomics and artificial intelligence analysis of CT data for the identification of prognostic features in multiple myeloma
Multiple Myeloma (MM) is a blood cancer implying bone marrow involvement, renal damages and osteolytic lesions. The skeleton involvement of MM is at the core of the present paper, exploiting radiomics and artificial inte…
BIG-bench Machine LearningPrognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma
Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most aggressive cancers with an extremely poor prognosis. Radiomics has shown prognostic ability in multiple types of cancer including PDAC. However, the prognostic v…
Object DetectionPrognosisTransfer Learning